Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Staying hydrated, eating smaller portions of protein-rich foods, and taking the injection at the same time each week can significantly reduce discomfort during escalation phases
Many clients report feeling an energy boost within hours of their injection
Similar studies have also found that PRNP, a ferroptosis-related gene, is significantly associated with cancer stage, main treatment outcome, and age of OC patients by mining differential genes (DEGs) of OC through public datasets
Inclusion Criteria Exclusion Criteria Timeline for a Trial Participant Screening Participants are screened for eligibility to participate in the trial Treatment Participants receive intravenous bimagrumab and subcutaneous semaglutide according to the dose escalation schedule Follow-up Participants are monitored for safety and effectiveness after treatment Extension Participants may continue to receive bimagrumab during the extension period What Are the Treatments Tested in This Trial
US$ 25.10
US$ 22.14
US$ 21.10
US$ 22.40
US$ 28.12
